4D Molecular Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $28.2M | $58.2M | $49.7M |
| FY2020 | $31.9M | $288.3M | $276.7M |
| FY2021 | $34.4M | $353.5M | $153.0M |
| FY2022 | $30.5M | $261.8M | $52.4M |
| FY2023 | $32.1M | $339.9M | $249.1M |
| FY2024 | $49.8M | $560.4M | $149.3M |
| FY2025 | $61.0M | $566.7M | $60.2M |